Aug 28, 2024 / 07:00AM GMT
Operator
Please begin your meeting.
Tobias Bjorklund - Novozymes A/S-Head of Investor Relations
Thank you, operator, and welcome, everyone, to Novonesis conference call for the first half year of 2024. My name is Tobias Björklund, as mentioned. And I'm heading up the Investor Relations here at Novonesis. At this call, our CEO, Ester Baiget; and our CFO, Rainer Lehmann, will review our performance and the key events over the first six months of the year as well as the outlook for the full year.
Attending today's call, we also have Jacob Paulsen, EVP of Food and Beverage Biosolutions; Amy Byrick, EVP of Human Health Biosolutions; Tina Fanø, EVP of Planetary Health Biosolutions; and Claus Fuglsang, Chief Scientific Officer. The conference call will take about 45 minutes, including Q&A. Please change to the next slide.
As usual, I would like to remind you that the information presented during the call is unaudited and that management may make forward-looking statements. These statements are based on current
Half Year 2024 Novozymes A/S Earnings Call Transcript
Aug 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers